- Sort by Sort ascending
- Job Title Sort ascending
- Site
- Location
- Division
- Business
- Functional Area
- Date Posted
| Job Title Sort ascending | Site | Location | Division | Business | Functional Area | Date Posted |
|---|---|---|---|---|---|---|
| Japan Program Manager | Head Office (Japan) (Pharmaceuticals) | Japan | Development | Innovative Medicines | Research & Development | Jan 05, 2025 |
| Manager, Global Program Regulatory Manager (GPRM) Japan | Head Office (Japan) (Pharmaceuticals) | Japan | Development | Innovative Medicines | Research & Development | Jan 05, 2025 |
| Process Expert | Sasayama | Japan | Operations | Innovative Medicines | Technical Operations | Dec 25, 2024 |
| Investigation Expert | Sasayama | Japan | Operations | Innovative Medicines | Quality | Dec 16, 2024 |
| Japan Program Clinical Head (IMM) | Head Office (Japan) (Pharmaceuticals) | Japan | Biomedical Research | Innovative Medicines | Research & Development | Dec 16, 2024 |
| MS&T Expansion Lead RLT Sasayama | Sasayama | Japan | Operations | Innovative Medicines | Technical Operations | Dec 16, 2024 |
| Market Access Lead/Senior Lead | Head Office (Japan) (Pharmaceuticals) | Japan | International | Innovative Medicines | Market Access | Dec 15, 2024 |
| Senior Lead, Early Medical Strategy | Head Office (Japan) (Pharmaceuticals) | Japan | International | Innovative Medicines | Research & Development | Dec 15, 2024 |
| Associate/Lead, Integrated Insights & Planning (Market Research) | Head Office (Japan) (Pharmaceuticals) | Japan | International | Innovative Medicines | Marketing | Dec 13, 2024 |
| Senior Statistical Programmer | Head Office (Japan) (Pharmaceuticals) | Japan | Development | Innovative Medicines | Research & Development | Dec 08, 2024 |
| Country Head of ERC, Japan | Head Office (Japan) (Pharmaceuticals) | Japan | Ethics Risk & Compliance | Innovative Medicines | Legal & Intellectual Property & Compl. | Dec 06, 2024 |
| Senior Manager, Owned Channel Strategy and Intelligence | Head Office (Japan) (Pharmaceuticals) | Japan | Corporate Affairs | CTS | Communications & Public Affairs | Dec 04, 2024 |
| SSO Feasibility Manager | Head Office (Japan) (Pharmaceuticals) | Japan | Development | Innovative Medicines | Research & Development | Dec 03, 2024 |
| Associate, Record-to-Report | Head Office (Japan) (Pharmaceuticals) | Japan | Finance | CTS | Audit & Finance | Dec 03, 2024 |
| Clinical Biospecimen Senior Scientist | Head Office (Japan) (Pharmaceuticals) | Japan | Development | Innovative Medicines | Research & Development | Dec 03, 2024 |
| Head Regulatory Writing | Head Office (Japan) (Pharmaceuticals) | Japan | Development | Innovative Medicines | Research & Development | Dec 03, 2024 |
| Japan Program Head (Neuroscience & GTx) | Head Office (Japan) (Pharmaceuticals) | Japan | Development | Innovative Medicines | Research & Development | Dec 03, 2024 |
| Japan Program Head (Immunology) | Head Office (Japan) (Pharmaceuticals) | Japan | Development | Innovative Medicines | Research & Development | Dec 03, 2024 |
| Associate or Manager, PHAD Japan | Head Office (Japan) (Pharmaceuticals) | Japan | Development | Innovative Medicines | Research & Development | Dec 03, 2024 |
| Customer Engagement Lead | Head Office (Japan) (Pharmaceuticals) | Japan | International | Innovative Medicines | Sales | Dec 03, 2024 |
| SSO Associate Clinical Project Manager | Head Office (Japan) (Pharmaceuticals) | Japan | Development | Innovative Medicines | Research & Development | Dec 03, 2024 |
| Manager, RA CMC Manager Japan | Head Office (Japan) (Pharmaceuticals) | Japan | Development | Innovative Medicines | Research & Development | Dec 03, 2024 |
| Project Engineer (Design Phase)_RLT Sasayama | Sasayama | Japan | Operations | Innovative Medicines | Technical Operations | Dec 03, 2024 |
| Sr Manager / Manager, Development Finance | Head Office (Japan) (Pharmaceuticals) | Japan | Finance | Innovative Medicines | Audit & Finance | Nov 18, 2024 |
| Medical Field Trainer | Head Office (Japan) (Pharmaceuticals) | Japan | International | Innovative Medicines | Research & Development | Nov 12, 2024 |
| Quality Control Staff | Sasayama | Japan | Operations | Innovative Medicines | Quality | Oct 18, 2024 |
| Quality Control Staff | Sasayama | Japan | Operations | Innovative Medicines | Quality | Oct 18, 2024 |
| Quality Control Staff | Sasayama | Japan | Operations | Innovative Medicines | Quality | Oct 18, 2024 |
| Quality Control Staff | Sasayama | Japan | Operations | Innovative Medicines | Quality | Oct 18, 2024 |
| Quality Control Staff | Sasayama | Japan | Operations | Innovative Medicines | Quality | Oct 18, 2024 |
| Quality Control Staff | Sasayama | Japan | Operations | Innovative Medicines | Quality | Oct 18, 2024 |
| Quality Control Staff | Sasayama | Japan | Operations | Innovative Medicines | Quality | Oct 18, 2024 |
| Quality Control Staff | Sasayama | Japan | Operations | Innovative Medicines | Quality | Oct 18, 2024 |
| Quality Control Staff | Sasayama | Japan | Operations | Innovative Medicines | Quality | Oct 18, 2024 |
| Quality Control Staff | Sasayama | Japan | Operations | Innovative Medicines | Quality | Oct 18, 2024 |
| Quality Control Staff | Sasayama | Japan | Operations | Innovative Medicines | Quality | Oct 18, 2024 |
| TA Strategy Lead, RLT (Prostate Cancer) | Head Office (Japan) (Pharmaceuticals) | Japan | International | Innovative Medicines | Marketing | Oct 07, 2024 |
| Manager, Financial Control & Compliance (FC&C) | Head Office (Japan) (Pharmaceuticals) | Japan | Finance | CTS | Audit & Finance | Oct 06, 2024 |
| TA Strategy Lead - GenMed | Head Office (Japan) (Pharmaceuticals) | Japan | International | Innovative Medicines | Marketing | Oct 02, 2024 |
| RLT Sasayama_Associate_Finance Business Planning and Analysis | Sasayama | Japan | Finance | Innovative Medicines | Audit & Finance | Sep 17, 2024 |
| Group Manager, MSL | Head Office (Japan) (Pharmaceuticals) | Japan | International | Innovative Medicines | Research & Development | Sep 05, 2024 |
| QC Analyst | Sasayama | Japan | Operations | Innovative Medicines | Quality | Sep 03, 2024 |
| Associate/Manager, MSL (Cardiovascular) | Head Office (Japan) (Pharmaceuticals) | Japan | International | Innovative Medicines | Research & Development | Aug 20, 2024 |
| Sr. TA Strategy Lead (Renal Therapy Area) | Head Office (Japan) (Pharmaceuticals) | Japan | International | Innovative Medicines | Marketing | Aug 07, 2024 |
| Technical System Lead (Qualification) | Sasayama | Japan | Operations | Innovative Medicines | Technical Operations | Jul 31, 2024 |
| Senior Specialist DDIT OPS Mfg Site IT | Sasayama | Japan | Operations | CTS | Information Technology | Jul 22, 2024 |
| Associate/Manager, MSL（Oncology） | Head Office (Japan) (Pharmaceuticals) | Japan | International | Innovative Medicines | Research & Development | Jul 22, 2024 |
| Senior Specialist - Automation Engineer | Sasayama | Japan | Operations | Research & Development | Jul 16, 2024 | |
| Lead, RWE and Evidence Excellence | Head Office (Japan) (Pharmaceuticals) | Japan | International | Innovative Medicines | Research & Development | Jul 10, 2024 |
| Associate Director Pipeline Management | Head Office (Japan) (Pharmaceuticals) | Japan | Development | Innovative Medicines | Research & Development | Jul 10, 2024 |
To report an adverse event or any drug related issues concerning Novartis medicinal products; please contact Novartis Patient Safety: Tel: +202 22861000 - Press 3 for reporting an adverse event.
E-mail: [email protected]
للإبلاغ عن أثر جانبى أو أي مشكلة دوائية متعلقة بمنتجات نوفارتس الطبية او الاجهزة ؛ يرجى الاتصال بقسم اليقظة الدوائية في شركة نوفارتس
+202 22861000 : الهاتف
ثم اضغط 3 للإبلاغ عن أثر جانبي +
[email protected] البريد الإلكترونى